Nevro Corp (NVRO)

Sector:
HEALTH CARE
Industry:
HEALTH CARE SUPPLIES
SIC:
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
CEO:
D. Keith Grossman
Employees:
1,090
1800 BRIDGE PARKWAY, REDWOOD CITY, CA 94065
650-251-0005

Nevro Corp. provides products for patients suffering from chronic pain in the United States and internationally. The company sells its products through its direct sales force, and a network of sales agents and independent distributors. Nevro was incorporated in 2006 and is headquartered in Redwood City, California.

Data derived from most recent annual or quarterly report
Market Cap 605.373 Million Shares Outstanding36.12 Million Avg 30-day Volume 587.992 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS2.3
Price to Revenue1.6428 Debt to Equity0.6574 EBITDA-98.511 Million
Price to Book Value2.4317 Operating Margin-25.276300000000003 Enterprise Value562.199 Million
Current Ratio6.546 EPS Growth-7.394 Quick Ratio4.881
1 Yr BETA 1.0808 52-week High/Low 48.1 / 13.98 Profit Margin-24.2228
Operating Cash Flow Growth-376.0757 Free Cash Flow to Firm (FCFF) TTM -103.428 Million Free Cash Flow to Equity (FCFE) TTM-83.934 Million
Altman Z-Score0.8564
View SEC Filings from NVRO instead.

View recent insider trading info

Nevro Corp YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding NVRO (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding NVRO

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2023-11-14 by CARTER RICHARD B.
  • 4: filed on 2023-10-06 by RASHID KASHIF
  • 4: filed on 2023-10-03 by KOSARAJU SRIDHAR
  • 4: filed on 2023-09-06 by CARTER RICHARD B.
  • 4: filed on 2023-08-30 by MACLEOD RODERICK H.
  • 4: filed on 2023-08-30 by RASHID KASHIF
  • 4: filed on 2023-07-05 by KOSARAJU SRIDHAR
  • 4: filed on 2023-06-21 by SILLER GREG
  • 3: filed on 2023-06-21 by SILLER GREG
  • 4: filed on 2023-06-20 by MACLEOD RODERICK H.

    • Events (8k)

  • 8-K: filed on 2023-11-01:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-08-01:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-07-07:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2023-06-05:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2023-05-30:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2023-04-26:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-04-19:
    Item 2.02: Results of Operations and Financial Condition
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-02-16:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-01-09:
    Item 2.02: Results of Operations and Financial Condition
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-11-02:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits

    • Proposed Sales (Form 144)

    Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    CARTER RICHARD B. CHIEF ACCOUNTING OFFICER

    • Officer
    		 37,453 2023-11-11 6

    GROSSMAN D KEITH EXECUTIVE CHAIRMAN

    • Officer
    • Director
    		 217,920 2023-10-24 8

    RASHID KASHIF GENERAL COUNSEL

    • Officer
    		 92,877 2023-10-04 7

    DEMANE MICHAEL F

    • Director
    		 466,545 2023-09-30 7

    WEATHERMAN ELIZABETH H

    • Director
    		 53,488 2023-09-30 5

    FISCHER FRANK M

    • Director
    		 55,563 2023-09-30 5

    KOSARAJU SRIDHAR

    • Director
    		 16,665 2023-09-30 5

    MACLEOD RODERICK H. CHIEF FINANCIAL OFFICER

    • Officer
    		 66,177 2023-08-28 6

    SILLER GREG CHIEF COMMERCIAL OFFICER

    • Officer
    		 0 2023-06-19 2

    MCCORMICK SHAWN

    • Director
    		 26,866 2023-06-07 2

    PELLEGRINI NIAMH LOUISE CHIEF COMMERCIAL OFFICER

    • Officer
    		 85,967 2023-05-28 4

    OBOYLE KEVIN C

    • Director
    		 24,227 2023-05-25 1

    SIEGEL SUSAN E

    • Director
    		 12,792 2023-05-25 1

    PRANGE KAREN

    • Director
    		 14,779 2023-05-25 1

    THORNAL KEVIN R PRESIDENT & CEO

    • Officer
    		 135,623 2023-04-24 2

    VALE BRAD

    • Director
    		 8,198 2021-05-25 0

    GALLIGAN ANDREW H CHIEF FINANCIAL OFFICER

    • Officer
    		 59,179 2020-06-04 0

    JAEGER WILFRED E

    • Director
    		 38,039 2020-05-21 0

    SCHMITZ PATRICK VICE PRESIDENT, OPERATIONS

    • Officer
    		 18,658 2020-02-28 0

    ALLEAVITCH DOUG VP, QUALITY

    • Officer
    		 25,590 2019-11-25 0

    CHRISTOFOROU CHRISTOFER VP, RESEARCH & DEVELOPMENT

    • Officer
    		 19,570 2019-11-01 0

    CARTER MICHAEL COLLIER VICE PRESIDENT, SALES

    • Officer
    		 39,350 2019-02-20 0

    ELGHANDOUR RAMI PRESIDENT & CEO

    • Officer
    • Director
    		 122,387 2019-01-03 0

    EARNHARDT LISA D

    • Director
    		 5,303 2018-05-21 0

    BEHBAHANI ALI

    • Director
    		 5,390 2018-05-21 0

    ALECXIH JAMES VICE PRESIDENT, SALES

    • Officer
    		 0 2017-12-12 0

    ENXING MICHAEL VP OF SALES

    • Officer
    		 40,463 2017-04-04 0

    WALKER ANDRE SENIOR VP,RESEARCH&DEVELOPMENT

    • Officer
    		 961 2016-06-08 0

    JOHNSON & JOHNSON

    JOHNSON & JOHNSON INNOVATION - JJDC, INC.

    • 10% Owner
    		 No longer subject to file 2015-12-31 0

    BAY CITY CAPITAL LLC

    BAY CITY CAPITAL FUND IV, L.P.

    BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP

    BAY CITY CAPITAL MANAGEMENT IV LLC

    • FORMER 10% BENEFICIAL OWNERFORMER 10% BENEFICIAL OWNERFORMER 10% BENEFICIAL OWNERFORMER 10% BENEFICIAL OWNER
    		 36,403 2015-06-08 0

    PLIAM NATHAN B

    • Director
    		 1,725,379 2015-06-08 0

    SHANKAR BALAKRISHNAN VP, OPERATIONS

    • Officer
    		 0 2015-01-13 0

    THREE ARCH MANAGEMENT IV, L.L.C.

    THREE ARCH PARTNERS IV LP

    THREE ARCH ASSOCIATES IV LP

    JAEGER WILFRED E

    WAN MARK A

    • Director
    • FORMER 10% BENEFICIAL OWNERFORMER 10% BENEFICIAL OWNERFORMER 10% BENEFICIAL OWNERFORMER 10% BENEFICIAL OWNERFORMER 10% BENEFICIAL OWNER
    		 2,210,569 2014-11-12 0

    AMV PARTNERS II LP

    • FORMER 10% BENEFICIAL OWNER
    		 No longer subject to file 2014-11-12 0

    NOVO A/S

    • 10% Owner
    • SEE REMARKS
    		 No longer subject to file 2014-11-12 0

    BISGAARD PETER

    • Director
    		 0 2014-11-05 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    CARTER RICHARD B. - Officer CHIEF ACCOUNTING OFFICER

    		2023-11-14 18:54:57 -0500 2023-11-11 F 230 $15.04 d 37,453 direct -0.9953 -4.5082 0.0 1 -5.9719 5

    GROSSMAN D KEITH - Director - Officer EXECUTIVE CHAIRMAN

    		2023-10-26 16:34:25 -0400 2023-10-24 F 6,012 $15.75 d 217,920 direct -1.8006 11.2881 11.2881 6 -1.8006 2

    RASHID KASHIF - Officer GENERAL COUNSEL

    		2023-10-06 17:14:02 -0400 2023-10-04 F 1,879 $18.07 d 92,877 direct 7.2406 -3.1927 -5.4732 7.2406 2 -19.1562 16

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    NEVRO CORP NVRO 2023-11-30 19:15:04 UTC 4.9119 0.4081 550000
    NEVRO CORP NVRO 2023-11-30 18:45:04 UTC 4.9119 0.4081 550000
    NEVRO CORP NVRO 2023-11-30 18:15:04 UTC 4.9119 0.4081 550000
    NEVRO CORP NVRO 2023-11-30 17:45:04 UTC 4.9119 0.4081 550000
    NEVRO CORP NVRO 2023-11-30 17:15:04 UTC 4.9119 0.4081 550000
    NEVRO CORP NVRO 2023-11-30 16:45:03 UTC 4.9119 0.4081 550000
    NEVRO CORP NVRO 2023-11-30 16:15:04 UTC 4.9119 0.4081 550000
    NEVRO CORP NVRO 2023-11-30 15:45:04 UTC 4.9119 0.4081 550000
    NEVRO CORP NVRO 2023-11-30 15:15:04 UTC 4.9119 0.4081 550000
    NEVRO CORP NVRO 2023-11-30 14:45:04 UTC 4.9119 0.4081 550000
    NEVRO CORP NVRO 2023-11-30 14:15:04 UTC 4.9119 0.4081 550000
    NEVRO CORP NVRO 2023-11-30 13:45:04 UTC 4.9119 0.4081 550000
    NEVRO CORP NVRO 2023-11-30 13:15:04 UTC 4.9119 0.4081 550000
    NEVRO CORP NVRO 2023-11-30 12:45:03 UTC 4.9119 0.4081 550000
    NEVRO CORP NVRO 2023-11-29 22:15:05 UTC 4.9119 0.4081 550000
    NEVRO CORP NVRO 2023-11-29 21:45:04 UTC 4.9119 0.4081 550000
    NEVRO CORP NVRO 2023-11-29 21:15:05 UTC 4.9119 0.4081 550000
    NEVRO CORP NVRO 2023-11-29 20:45:04 UTC 4.9119 0.4081 550000
    NEVRO CORP NVRO 2023-11-29 20:15:03 UTC 4.9119 0.4081 550000
    NEVRO CORP NVRO 2023-11-29 19:45:04 UTC 4.9119 0.4081 550000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin
    FundVantage Trust- Gotham Hedged Plus Fund NVRO -82.0 shares, $-3247.2 2022-12-30 N-PORT
    WASATCH FUNDS TRUST- Wasatch Long/Short Alpha Fund NVRO -16926.0 shares, $-325317.72 2023-09-30 N-PORT

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    WhaleWisdom Logo

    Elevate your investments